SCOPUS 정보 검색 플랫폼

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 57, Issue 1, 2014, Pages 25-35

Preparation of clinical-grade 89Zr-panitumumab as a positron emission tomography biomarker for evaluating epidermal growth factor receptor-targeted therapy

(4) Wei, Ling a Shi, Jianfeng a Afari, George a Bhattacharyya, Sibaprasad a

a SAIC FREDERICK INC (United States)

Author keywords

89Zr immuno PET; Clinical production; Panitumumab; PET imaging

Indexed keywords

DISEASES; MONOCLONAL ANTIBODIES; POSITRONS; PROBES; QUALITY CONTROL; SPECIFICATIONS;

89ZR-IMMUNO-POSITRON EMISSION TOMOGRAPHY; BIO-CONJUGATED; CLINICAL PRODUCTION; EPIDERMAL GROWTH FACTOR RECEPTORS; HUMAN MONOCLONAL ANTIBODIES; PANITUMUMAB; POSITRON EMISSION TOMOGRAPHY IMAGING; QUALITY CONTROL TESTS; ROBUST PROCEDURES; TOMOGRAPHY IMAGING;

POSITRON EMISSION TOMOGRAPHY;

BIOLOGICAL MARKER; DEFEROXAMINE; EPIDERMAL GROWTH FACTOR RECEPTOR; PANITUMUMAB; PANITUMUMAB ZR 89; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ARTICLE; BINDING ASSAY; COLORECTAL CANCER; DRUG CONJUGATION; DRUG DETERMINATION; DRUG PURIFICATION; DRUG QUALITY; DRUG SPECIFICITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; ISOTOPE LABELING; MOLECULARLY TARGETED THERAPY; POSITRON EMISSION TOMOGRAPHY; QUALITY CONTROL; RADIOACTIVITY; RADIOCHEMISTRY; THIN LAYER CHROMATOGRAPHY;

89ZR-IMMUNO-PET; CLINICAL PRODUCTION; PANITUMUMAB; PET IMAGING;

ANTIBODIES, MONOCLONAL; ENDOTOXINS; HUMANS; HYDROGEN-ION CONCENTRATION; MOLECULAR TARGETED THERAPY; POSITRON-EMISSION TOMOGRAPHY; QUALITY CONTROL; RADIOCHEMISTRY; RADIOISOTOPES; RADIOPHARMACEUTICALS; RECEPTOR, EPIDERMAL GROWTH FACTOR; ZIRCONIUM;

EID: 84892829596 PISSN: 03624803 EISSN: 10991344 Source Type: Journal
DOI: 10.1002/jlcr.3134 Document Type: Article

Times cited : (15)

References (27)

1
- 52649160344
- A. W. Burgess, Growth Factors 2008, 26, 263-274.
- (2008) Growth Factors , vol.26 , pp. 263-274
- Burgess, A.W.¹

2
- 0036016088
- F. Ciardiello, G. Tortora, Expert Opin. Invest. Drugs 2002, 11, 755-768.
- (2002) Expert Opin. Invest. Drugs , vol.11 , pp. 755-768
- Ciardiello, F.¹ Tortora, G.²

3
- 60549084533
- M. A. Pantaleo, et al,., Ann. Oncol. 2009, 20, 213-226.
- (2009) Ann. Oncol. , vol.20 , pp. 213-226
- Pantaleo, M.A.¹

4
- 85167468536
- P. Slobbe, A. J. Poot, A. D. Windhorst, et al,., Drug Discov. Today 2012, 17, 1174-1187.
- (2012) Drug Discov. Today , vol.17 , pp. 1174-1187
- Slobbe, P.¹ Poot, A.J.² Windhorst, A.D.³

5
- 34248359388
- A. P. Dei Tos, Int. J. Biol. Biomarkers 2007, 22, S3-S9.
- (2007) Int. J. Biol. Biomarkers , vol.22
- Dei Tos, A.P.¹

6
- 20444502086
- A. P. Dei Tos, I. Ellis, Eur. J. Cancer 2005, 41, 1383-1392.
- (2005) Eur. J. Cancer , vol.41 , pp. 1383-1392
- Dei Tos, A.P.¹ Ellis, I.²

7
- 79958189601
- S. Bhattacharyya, M. Dixit, Dalton Trans. 2011, 50, 6112-6128.
- (2011) Dalton Trans. , vol.50 , pp. 6112-6128
- Bhattacharyya, S.¹ Dixit, M.²

8
- 78649479373
- J. W. Hicks, H. F. VanBrocklin, A. A. Wilson, et al,., Molecules 2010, 15, 8260-8278.
- (2010) Molecules , vol.15 , pp. 8260-8278
- Hicks, J.W.¹ Vanbrocklin, H.F.² Wilson, A.A.³

9
- 45349097237
- M. Wu, A. Rivkin, T. Pham, Clin. Ther. 2008, 30, 14-30.
- (2008) Clin. Ther. , vol.30 , pp. 14-30
- Wu, M.¹ Rivkin, A.² Pham, T.³

10
- 85167477436
- [30 September 2012]
- http://www.cancer.gov/cancertopics/druginfo/panitumumab [30 September 2012].

11
- 84871928766
- A. M. Deri, et al,., Nucl. Med. Biol. 2013, 40, 3-14.
- (2013) Nucl. Med. Biol. , vol.40 , pp. 3-14
- Deri, A.M.¹

12
- 77953927831
- T. K. Nayak, K. Germastani, K. E. Baidoo, D. E. Milenic, M. W. Brechbiel, J. Nucl. Med. 2010, 51, 942-950.
- (2010) J. Nucl. Med. , vol.51 , pp. 942-950
- Nayak, T.K.¹ Germastani, K.² Baidoo, K.E.³ Milenic, D.E.⁴ Brechbiel, M.W.⁵

13
- 77749309983
- e8859.
- J. P. Holland, E. Caldas-Lopes, V. Divilov, V. A. Longo, T. Taldone, D. Zatorska, G. Chiosis, J. S. Lewis, PloS ONE 2010, 5, e8859, 1-11.
- (2010) PloS ONE , vol.5 , pp. 1-11
- Holland, J.P.¹ Caldas-Lopes, E.² Divilov, V.³ Longo, V.A.⁴ Taldone, T.⁵ Zatorska, D.⁶ Chiosis, G.⁷ Lewis, J.S.⁸

14
- 77949268357
- L. R. Perk, M. Vosjan, G. W. M. Visser, M. Budde, P. Jurek, G. Keifer, G. A. M. S. van Dongen, Eur. J. Nucl. Med. Mol. Imaging 2009, 37, 250-258.
- (2009) Eur. J. Nucl. Med. Mol. Imaging , vol.37 , pp. 250-258
- Perk, L.R.¹ Vosjan, M.² Visser, G.W.M.³ Budde, M.⁴ Jurek, P.⁵ Keifer, G.⁶ Van Dongen, G.A.M.S.⁷

15
- 33646241548
- P. K. E. Börjesson, Y. W. S. Jauw, et al,., Clin. Cancer Res. 2006, 12, 2133.
- (2006) Clin. Cancer Res. , vol.12 , pp. 2133
- Börjesson, P.K.E.¹ Jauw, Y.W.S.²

16
- 77954042065
- J. W. D. M. Vosjan, et al,., Nat. Protocol 2010, 5, 739-743.
- (2010) Nat. Protocol , vol.5 , pp. 739-743
- Vosjan, J.W.D.M.¹

17
- 84855385828
- T. K. Nayak, K. Germestani, D. E. Milenic, M. W. Brechbiel, J. Nucl. Med. 2012, 53 (1), 113-120.
- (2012) J. Nucl. Med. , vol.53 , Issue.1 , pp. 113-120
- Nayak, T.K.¹ Germestani, K.² Milenic, D.E.³ Brechbiel, M.W.⁴

18
- 84876734927
- S. Bhattacharyya, et al,., Nucl. Med. Biol. 2013, 40, 451-457.
- (2013) Nucl. Med. Biol. , vol.40 , pp. 451-457
- Bhattacharyya, S.¹

19
- 85167472046
- [04 April 2013]
- http://clinicaltrials.gov/show/NCT00326495 [04 April 2013].

20
- 84877307347
- A. J. Chang, et al,., Mol. Imaging, 2013, 12, 17-27.
- (2013) Mol. Imaging , vol.12 , pp. 17-27
- Chang, A.J.¹

21
- 69249216426
- J. P. Holland, Y. Sheh, J. Lewis, Nucl. Med. Biol. 2009, 36, 729-739.
- (2009) Nucl. Med. Biol. , vol.36 , pp. 729-739
- Holland, J.P.¹ Sheh, Y.² Lewis, J.³

22
- 46749102563
- P. Zanzonico, J. Nucl. Med. 2009, 49, 1114-1131.
- (2009) J. Nucl. Med. , vol.49 , pp. 1114-1131
- Zanzonico, P.¹

23
- 71849104860
- O. H. Lowry, N. J. Rosebrough, A. L. Farr, R. J. Randall, J. Biol. Chem. 1951, 193, 265-275.
- (1951) J. Biol. Chem. , vol.193 , pp. 265-275
- Lowry, O.H.¹ Rosebrough, N.J.² Farr, A.L.³ Randall, R.J.⁴

24
- 0021512252
- C. F. Meares, M. J. McCall, D. T. Reardan, D. A. Goodwin, C. I. Diamanti, M. McTigue, Anal. Biochem. 1984, 142, 68-78.
- (1984) Anal. Biochem. , vol.142 , pp. 68-78
- Meares, C.F.¹ McCall, M.J.² Reardan, D.T.³ Goodwin, D.A.⁴ Diamanti, C.I.⁵ McTigue, M.⁶

25
- 84941940170
- 278607.
- M. Dixit, J. Shi, W. Ling, et al,., Int. J. Mol. Imaging. 2013, 2013, 278607, 1-10.
- (2013) Int. J. Mol. Imaging , vol.2013 , pp. 1-10
- Dixit, M.¹ Shi, J.² Ling, W.³

26
- 0034923735
- S. Liu, D. S. Edward, Bioconj. Chem. 2001, 12 (4), 554-558. organizations imply endorsement by the US Government. The authors are grateful to Dr. Lawrence Szajek of cyclotron facility at NIH Bethesda for providing Zr-oxalate.
- (2001) Bioconj. Chem. , vol.12 , Issue.4 , pp. 554-558
- Liu, S.¹ Edward, D.S.²

27
- 85167472969
- FDA Guidance for Industry: ICH Q3C Revision 2 (2/2012) [13 August 2012].
- FDA Guidance for Industry: ICH Q3C-Tables and List, Revision 2 (2/2012). http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/ucm073395.pdf [13 August 2012].
- Tables and List

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.